Cervical Cancer Screening

Last updated: January 31, 2017

CMS Measure ID: CMS124v5
Version: 5
NQF Number: 0032
Measure Description:

Percentage of women 21-64 years of age who were screened for cervical cancer using either of the following criteria:

  • Women age 21-64 who had cervical cytology performed every 3 years
  • Women age 30-64 who had cervical cytology/human papillomavirus (HPV) co-testing performed every 5 years
Initial Patient Population:

Women 23-64 years of age with a visit during the measurement period

Denominator Statement:

Equals Initial Population

Denominator Exclusions:

Women who had a hysterectomy with no residual cervix

Numerator Statement:

Women with one or more screenings for cervical cancer. Appropriate screenings are defined by any one of the following criteria:

  • Cervical cytology performed during the measurement period or the two years prior to the measurement period for women who are at least 21 years old at the time of the test
  • Cervical cytology/human papillomavirus (HPV) co-testing performed during the measurement period or the four years prior to the measurement period for women who are at least 30 years old at the time of the test
Numerator Exclusions:

Not Applicable

Denominator Exceptions:

None

Measure Steward: National Committee for Quality Assurance
Domain: Effective Clinical Care
Previous Version: Cervical Cancer Screening
Improvement Notation:

Higher score equals better quality

Guidance:

To ensure the measure is only looking for a cervical cytology test only after a woman turns 21 years of age, the youngest age in the initial population is 23

Specifications

Release Notes

Header

  • Updated Clinical Recommendation Statement.

    Section: Clinical Recommendation Statement

    Source: None

  • ​Updated Copyright.

    Section: Copyright

    Source: Annual Update

  • Added an HPV/Pap co-test in the past 5 years for women 30-64 years of age to the numerator to align with updated USPSTF guidelines.

    Section: Description

    Source: JIRA (CQM-1440)

  • Incremented eMeasure Version number.

    Section: eMeasure Version number

    Source: Annual Update

  • Added guidance to explain the age ranges in the measure logic and description.

    Section: Guidance

    Source: JIRA (CQM-1440)

  • Added an HPV/Pap co-test in the past 5 years for women 30-64 years of age to the numerator to align with updated USPSTF guidelines.

    Section: Numerator

    Source: JIRA (CQM-1440)

  • Updated Rationale.

    Section: Rationale

    Source: Measure Lead

  • Updated References.

    Section: Reference

    Source: Measure Lead

Logic

  • Added an HPV/Pap co-test in the past 5 years for women 30-64 years of age to the numerator to align with updated USPSTF guidelines.

    Section: Numerator

    Source: JIRA (CQM-1440)

  • Value set Female (2.16.840.1.113883.3.560.100.2): Changed code system from 'AdministrativeSex' to 'AdministrativeGender'.

    Section: QDM Data Elements

    Source: Code System Update

  • Value Set HPV Test( 2.16.840.1.113883.3.464.1003.110.12.1059): Added value set HPV Test to measure.

    Section: QDM Data Elements

    Source: None

Value Set

  • Value set Female (2.16.840.1.113883.3.560.100.2): Changed code system from 'AdministrativeSex' to 'AdministrativeGender'.

    Section: None

    Source: Code System Update

  • Value Set HPV Test( 2.16.840.1.113883.3.464.1003.110.12.1059): Added value set HPV Test to measure.

    Section: None

    Source: None

External Resources